Proregulations is excited to announce its participation in the 29th CBA Annual Conference, which will be held at the Marriott Washingtonian Center (9751 Washingtonian Blvd, Gaithersburg, MD 20878), on June 9, 2024, 07:45 am - 5:30 pm. About CBA The Chinese Biopharmaceutical Association (CBA), founded in 1995, is an independent, non-political, non-profit professional organization with more than 700 active members and 100 institutional members. As a biopharma organization that gathers industry elites and shares cutting-edge wisdom, CBA aims to promote scientific research, technology development and commercial cooperation in the field of biomedicine. The CBA Annual Conference is its signature event, attracting thousands of scientists, entrepreneurs, policy makers and industry leaders from around the world each year, and is one of the largest annual gatherings of the biopharmaceutical industry between the United States and China. For further information on CBA, please visit cba-usa.org. Proregulations and CBA At Proregulations, we understand that compliance is not only the cornerstone of a pharmaceutical company's existence, but also the key to driving innovation and sustainable growth. As a specialized compliance service provider, our company is committed to helping our clients navigate the complex and ever-changing regulatory environment. Our compliance solutions for the pharmaceutical sector cover the entire lifecycle from regulatory counseling, registration strategy development, product testing, to application materials preparation and submission. Browse our services to learn how we help our clients in the pharmaceutical industry avoid regulatory compliance risks. The theme of this year's CBA Annual Conference is "Pioneering Biopharma Innovations: Scientific Breakthroughs, Global Development & Regulatory Harmonization, and Entrepreneurship." One of the main focuses of the conference will be developments in the field of pharmaceutical regulation. As a leading provider of regulatory services, we will share our technology, knowledge and experience. We will present our latest achievements and case studies in the field of regulatory affairs to potential partners We will discuss compliance challenges and solutions with the attendees We will exchange the latest industry trends with our industry peers We will actively seek cooperation opportunities with pharmaceutical companies We cordially invite you to attend the 29th CBA Annual Conference and welcome you to visit our booth for face-to-face communication with us. This will be an excellent time to learn more about our services and explore cooperation opportunities. If you are interested in our services or need more information, please contact us. We look forward to discussing compliance challenges and opportunities for the pharmaceutical industry with you at the CBA Annual Conference.